Scientists are expressing some doubts in regards to the Food and Drug Administration’s emergency use authorization for convalescent plasma as a remedy for Covid-19 sufferers. In a Sunday information briefing, President Donald Trump touted the remedy as a “breakthrough.” Former FDA chief Dr. Scott Gottlieb instructed CNBC that whereas there was sufficient knowledge to justify the authorization, the remedy will not be a “home run.”
The following knowledge was compiled by Johns Hopkins University:
- Global instances: More than 23.four million
- Global deaths: At least 809,300
- U.S. instances: More than 5.7 million
- U.S. deaths: At least 176,800
Comments
Loading…